[go: up one dir, main page]

ATE66208T1 - Diarylmethan-sulfonamid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. - Google Patents

Diarylmethan-sulfonamid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Info

Publication number
ATE66208T1
ATE66208T1 AT87400556T AT87400556T ATE66208T1 AT E66208 T1 ATE66208 T1 AT E66208T1 AT 87400556 T AT87400556 T AT 87400556T AT 87400556 T AT87400556 T AT 87400556T AT E66208 T1 ATE66208 T1 AT E66208T1
Authority
AT
Austria
Prior art keywords
pct
image
diarylmethane
preparation
pharmaceutical compositions
Prior art date
Application number
AT87400556T
Other languages
English (en)
Inventor
Pierre Roger
Jean-Paul Fournier
Alain Martin
Jean Choay
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of ATE66208T1 publication Critical patent/ATE66208T1/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/12Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms
    • C07D295/125Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/13Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly or doubly bound nitrogen atoms with the ring nitrogen atoms and the substituent nitrogen atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/14Radicals substituted by singly bound hetero atoms other than halogen
    • C07D333/18Radicals substituted by singly bound hetero atoms other than halogen by sulfur atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D333/00Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/06Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
    • C07D333/22Radicals substituted by doubly bound hetero atoms, or by two hetero atoms other than halogen singly bound to the same carbon atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Epoxy Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Saccharide Compounds (AREA)
AT87400556T 1986-03-12 1987-03-12 Diarylmethan-sulfonamid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen. ATE66208T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR8603537A FR2598412B1 (fr) 1986-03-12 1986-03-12 Nouveaux derives de diarylcetones et leurs procedes de preparation et les compositions pharmaceutiques les contenant
EP87400556A EP0238401B1 (de) 1986-03-12 1987-03-12 Diarylmethan-Sulfonamid-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen

Publications (1)

Publication Number Publication Date
ATE66208T1 true ATE66208T1 (de) 1991-08-15

Family

ID=9333058

Family Applications (1)

Application Number Title Priority Date Filing Date
AT87400556T ATE66208T1 (de) 1986-03-12 1987-03-12 Diarylmethan-sulfonamid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.

Country Status (16)

Country Link
US (1) US4980349A (de)
EP (1) EP0238401B1 (de)
JP (1) JPS63502666A (de)
AT (1) ATE66208T1 (de)
AU (1) AU598248B2 (de)
CA (1) CA1296003C (de)
DE (1) DE3772074D1 (de)
DK (1) DK587387A (de)
ES (1) ES2026554T3 (de)
FR (1) FR2598412B1 (de)
GR (1) GR3002488T3 (de)
IL (1) IL81878A (de)
NZ (1) NZ219604A (de)
PT (1) PT84473B (de)
WO (1) WO1987005601A2 (de)
ZA (1) ZA871802B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5391705A (en) * 1991-03-15 1995-02-21 Merrell Dow Pharmaceuticals Inc. Polyfluorinated tripeptide thrombin inhibitors
US6069232A (en) * 1995-10-02 2000-05-30 Hoechst Marion Roussel, Inc. Polyfluoroalkyl tryptophan tripeptide thrombin inhibitors
US5739354A (en) * 1996-03-26 1998-04-14 Hoechst Marion Roussel, Inc. Process for the preparation of N-methyl-D-phenylalanyl-N- 1- 3- (aminoiminomethyl)amino!propyl!-3,3-difluoro-2-oxohexyl!-L-prolinamide
EP2053034B1 (de) 2003-11-20 2018-01-24 Solvay Sa Verfahren zur Herstellung eines Chlorhydrins
CN106366000A (zh) * 2016-08-30 2017-02-01 枣阳凤泽精细化工有限公司 一种2‑氯‑5‑硝基二苯甲酮的制备方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA634170A (en) * 1962-01-09 Schraufstatter Ernst Aromatic sulfanamides
US3666779A (en) * 1967-07-15 1972-05-30 Hoechst Ag Sulfonamido carboxylic acids
JPS518939B2 (de) * 1971-12-29 1976-03-22
FR2201883B1 (de) * 1972-10-05 1975-10-31 Roussel Uclaf
GB1447054A (en) * 1973-06-28 1976-08-25 American Home Prod 2-n-alkyl-2-imidazolinyl-phenyl ketones
CA1072359A (en) * 1974-10-08 1980-02-26 Hiroyuki Konishi Method for controlling the growth of plants
US4198519A (en) * 1976-07-30 1980-04-15 Beecham Group Limited Anti-inflammatory compounds
DE3000377A1 (de) * 1980-01-07 1981-07-09 Boehringer Mannheim Gmbh, 6800 Mannheim Neue sulfonamide, verfahren zu deren herstellung sowie diese verbindungen enthaltende arzneimittel
FR2504528A1 (fr) * 1981-04-23 1982-10-29 Choay Sa Dialcoxy (2,4) benzenesulfonamides n-substitues
CA1214170A (fr) * 1981-06-16 1986-11-18 Patrick Choay Procedes de preparation de nouveaux composes du type arylbenzenesulfonamide

Also Published As

Publication number Publication date
FR2598412B1 (fr) 1988-10-21
US4980349A (en) 1990-12-25
IL81878A0 (en) 1987-10-20
IL81878A (en) 1991-06-30
WO1987005601A3 (fr) 1988-03-24
WO1987005601A2 (fr) 1987-09-24
DE3772074D1 (de) 1991-09-19
DK587387D0 (da) 1987-11-10
ZA871802B (en) 1987-11-25
AU598248B2 (en) 1990-06-21
CA1296003C (fr) 1992-02-18
EP0238401B1 (de) 1991-08-14
PT84473B (pt) 1989-10-04
AU7167087A (en) 1987-10-09
ES2026554T3 (es) 1992-05-01
EP0238401A2 (de) 1987-09-23
GR3002488T3 (en) 1992-12-30
EP0238401A3 (en) 1987-12-02
JPS63502666A (ja) 1988-10-06
FR2598412A1 (fr) 1987-11-13
DK587387A (da) 1988-01-08
PT84473A (fr) 1987-04-01
NZ219604A (en) 1990-06-26

Similar Documents

Publication Publication Date Title
DE59203704D1 (de) Biphenylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung.
ATE40368T1 (de) Xanthin-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
ATE1288T1 (de) Amino-pyrimidin-carbanilide, verfahren zu ihrer herstellung, diese verbindungen enthaltende arzneimittel.
ATE71375T1 (de) Substituierte 6-fluor-4-oxo-1,4-dihydrochinolin-3-carbonsaeure ; deren derivate; diese verbindung enthaltende pharmazeutische zubereitungen und verfahren zur herstellung dieser verbindungen.
ATE103893T1 (de) 24-homo-vitamin-d-derivate, verfahren zu ihrer herstellung; diese derivate enthaltende pharmazeutische praeparate sowie deren verwendung als arzneimittel.
GB2187188B (en) Neuroleptic carboxamides, their preparation and use, and pharmaceutical compositions containing them
DE68917220D1 (de) Phenylpyridon-Derivate, Verfahren zu ihrer Herstellung und diese enthaltende pharmazeutische Zusammensetzungen.
ATE66208T1 (de) Diarylmethan-sulfonamid-derivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zusammensetzungen.
PT77309B (de) Isochinolinderivate verfahren zu ihrer herstellung pharmazeutische praeparate auf basis dieser verbindungen und ihre verwendung
DE69015787D1 (de) Thiophenderivate, Verfahren zu deren Herstellung und sie enthaltende pharmazeutische Zusammensetzungen.
DE3769563D1 (de) Neue derivate von 4,5-dihydro-oxazolen, verfahren zu ihrer herstellung und ihre verwendung.
ATE5145T1 (de) O-creatinolphosphatderivat mit therapeutischer wirkung, verfahren zu dessen herstellung und dessen pharmazeutische zusammensetzungen.
ATE68178T1 (de) 1,4-dihydropyridinderivate, verfahren zu ihrer herstellung und sie enthaltende pharmazeutische zusammensetzungen.
ATE59647T1 (de) Isoxazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutischen praeparate.
ATE90095T1 (de) Optisch aktive produkte von 20,21dinoreburnamenin-derivaten,verfahren zur herstellung, ihre verwendung als arzneimittel und diese enthaltende pharmazeutische zusammenstellungen.
ATE37370T1 (de) Triazolderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
ATE15042T1 (de) Indolizinderivate, verfahren zu ihrer herstellung und diese enthaltende pharmazeutische zubereitungen.
DE58907804D1 (de) Neue basisch substituierte 5-Halogen-Thienoisothiazol-3(2H)-on-1,1-dioxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende pharmazeutische Präparate.
HUT54682A (en) Process for producing 13-bromine- and 13,14-dibromine-ergoline derivatives and pharmaceutical preparatives containing these compounds
ATE753T1 (de) Neue substituierte 2-phen ylamino-1,3-tetrahydropyrimidine-(2), deren saeureadditionssalze, diese enthaltende arzneimittel und verfahren zur herstellung derselben.
ATE4541T1 (de) Alkyl- und cycloalkylsubstituierte 2-(2-(2hydroxy-3-tert.-butylamino-propoxy)-5-acylamino phenyl)-1,3,4-oxadiazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende pharmazeutische zubereitungen.
RU92016559A (ru) Производные диалкокси-пиридинилбензимидазола, фармацевтическая композиция, способ ингибирования или лечения, способ их получения, применение и промежуточные соединения

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee